Severe Atopic Dermatitis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB14973 | Abrocitinib | A kinase inhibitor used to treat moderate-to-severe atopic dermatitis in adults. |
| DB11817 | Baricitinib | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. |
| DB00443 | Betamethasone | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. |
| DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
| DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |
| DB15091 | Upadacitinib | An oral Janus kinase (JAK)1-selective inhibitor used in the treatment of moderate to severe rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and severe atopic dermatitis, including in patients who did not respond well to other therapies. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00091 | Cyclosporine | 3 | Completed | 2 |